Market Exclusive

Analyst Downgrades – Astrazeneca PLC (NYSE:AZN) Stock Gets Downgraded By Morgan Stanley from Overweight to Equal Weight

Analyst Ratings For Astrazeneca PLC (NYSE:AZN)

Today, Astrazeneca PLC (NYSE:AZN) stock was downgraded by Morgan Stanley from Overweight to Equal Weight.

There are 2 sell ratings, 9 hold ratings, 9 buy ratings on the stock.

The current consensus rating on Astrazeneca PLC (NYSE:AZN) is Hold (Score: 2.35) with a consensus target price of $36.09 per share, a potential 19.24% upside.

Some recent analyst ratings include

Dividend information for Astrazeneca PLC (NYSE:AZN)

Astrazeneca PLC (NYSE:AZN) pays an annual dividend of Community Ranking: with a yield of 4.53% and an average dividend growth of -21.20% based on a 3 Year Average.

Dividend History for Astrazeneca PLC (NYSE:AZN)


Recent Trading Activity for Astrazeneca PLC (NYSE:AZN)
Shares of Astrazeneca PLC closed the previous trading session at 30.27 up +1.39 4.81% with 13,286,894 shares trading hands.

Exit mobile version